Last reviewed · How we verify

NCT05503212: BRAVO

Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions

Completed Last updated 14 August 2023
What this trial tests

trial testing Conservative treatment (CT) in Ischemic Stroke in 682 participants. Completed in 9 August 2023.

Timeline
1 January 2003
Primary endpoint
9 August 2023
9 August 2023

Quick facts

Lead sponsorCentre Hospitalier Universitaire Vaudois
StatusCompleted
Study typeOBSERVATIONAL
Enrollment682
Start date1 January 2003
Primary completion9 August 2023
Estimated completion9 August 2023
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire Vaudois

Who can join

18 and older, any sex, with Ischemic Stroke or Vertebral Artery Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Isolated vertebral artery occlusions (VAO) account for approximately one third of posterior circulation occlusions, but have been given the least attention among posterior circulation strokes. If the two recent ATTENTION and BAOCHE randomized clinical trials have proven the superiority of endovascular thrombectomy (EVT) in basilar artery occlusions, data on the effectiveness and harm of acute revascularization treatment on isolated VAO is scarce. We aim to investigate the impact of acute recanalisation treatments in acute ischemic stroke patients with isolated VAO. In the absence of RCT, observational data with appropriate statistical methods may give indications on benefits and harms of treating neglected stroke situations like acute vertebral occlusion. Results may also lay the basis for prospective studies, such as randomized clinical trials.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Outcomes and Safety of Revascularization Approaches for Stroke Related to Isolated Vertebral Artery Occlusions (BRAVO).
    Salerno A, Dunet V, Sykora M, Baumgartner P, et al · · 2026 · cited 1× · PMID 41804648 · DOI 10.1161/strokeaha.125.051675
  2. ESOC 2023 Abstract Book
    · 2023

Verify or expand the search:

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire Vaudois trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing